Return to ads
All categories


Posted by
Posting ads for 49 years
Gilenya has already gained approval in Russia and is currently waiting for approval in other countries.

German drug maker Merck KGaA has began selling their oral MS drug, cladribine, in Australia and Russia, and is awaiting regulatory decisions in the U.S..

Reply to this ad
Recently viewed ads
Saved ads
Please log in to browse your saved adverts or sign up if you don't have an account yet.
Popular Stuff